Janet Woodcock and Francis Collins

Janet Wood­cock and Fran­cis Collins dish on lessons learned from the pan­dem­ic

With al­most 550,000 Covid-19 deaths in the US, it might seem hard to fath­om any sil­ver lin­ings from such a tragedy. But NIH di­rec­tor Fran­cis Collins and FDA act­ing com­mis­sion­er Janet Wood­cock did their best on Wednes­day to ex­plain what they’ve seen and learned and what the coun­try needs to do to pre­pare for the next pan­dem­ic.

For Wood­cock, who led the ther­a­peu­tics side of Op­er­a­tion Warp Speed be­fore re­turn­ing to lead the FDA, Covid-19 clin­i­cal tri­al in­ef­fi­cien­cies and a dearth of com­mu­ni­ty-based re­search in­fra­struc­ture sit atop her list.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.